FDA Import Refusal AEK-3046284-7/61/1 — Boehringer Ingelheim Pharmaceuticals, Inc.
The FDA refused shipment AEK-3046284-7/61/1 from Boehringer Ingelheim Pharmaceuticals, Inc. (United States) on Mar 21, 2017. The refused product falls under Drugs and Biologics — MELOXICAM (ANTI-INFLAMMATORY, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 21, 2017
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62YDA07 MELOXICAM (ANTI-INFLAMMATORY, PART II)
- Charges
- 75